← All organizations

Taizhou Hanzhong biomedical co. LTD

Government

Also known as: Taizhou Hanzhong biomedical co. LTD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (10 distinct, 11 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT05647954Lead sponsorPhase 3Dec 31, 2022
NCT05652894Lead sponsorPhase 3Dec 20, 2022
NCT04741165Lead sponsorPhase 2Jan 7, 2021
NCT04574817Lead sponsorPhase 2Dec 28, 2020
NCT04750083Lead sponsorPhase 2/Phase 3Sep 25, 2020
NCT04738630Lead sponsorPhase 2Sep 25, 2020
NCT04486651Lead sponsorPhase 3Sep 16, 2020
NCT04825392Lead sponsorPhase 1Sep 5, 2019
NCT04750382Lead sponsorPhase 1/Phase 2Jul 15, 2019
NCT04749485Lead sponsorPhase 2Nov 8, 2018
NCT03704246Lead sponsorPhase 2Sep 30, 2018

Details

Last known activity: Dec 31, 2022